About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Effects of Propofol and Isoflurane on Pulmonary Vascular Resistance

NCT01212523·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Hospitals Bristol and Weston NHS Foundation Trust

Age

0–16

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

All children between 3 months and 16 years of age with pulmonary arterial hypertension undergoing a PVR study.

You may not be if

Children with a known adverse reaction to one of the study drugs eg malignant hyperpyrexia or a disorder of fatty acid oxidation.

The record

StatusCompleted

PhasePhase 4

Taking part10

StartedNov 2009

UpdatedDec 15, 2011

Conditions

Hypertension, Pulmonary

Where1

UH bristol NHS Trust
Bristol, United Kingdom

Clareo Health | Effects of Propofol and Isoflurane on Pulmonary Vascular Resistance